Clinical trial
Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina…
NCT00346437 · Cardium Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00346437 |
|---|---|
| Title | Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina |
| Lead sponsor | Cardium Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Angina Pectoris |
| Intervention type | Genetic |
| Interventions | Ad5FGF-4 vs. Placebo |
| Enrollment | 416 |
| Start date | Oct 1, 2001 |
| Primary completion | Jan 1, 2005 |
| Completion | Nov 1, 2008 |
| First posted | Jun 30, 2006 |
| Last update posted | Feb 9, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: